Emjard-L 5mg/25mg Tablets (14s)

Specification

Product Overview

Emjard l tab 5/25mg 14s is a medication manufactured by HOECHST PAK LTD containing linagliptin as its active ingredient. It is primarily used to treat type 2 diabetes by regulating blood sugar levels in the body.

Key Benefits

Helps control blood sugar levels

- Reduces the risk of complications related to diabetes

- Convenient once-daily dosing

- Improves overall quality of life for individuals with type 2 diabetes

How It Works

Linagliptin works by inhibiting the enzyme DPP-4, which is responsible for breaking down incretin hormones in the body. By blocking this enzyme, linagliptin helps increase the levels of incretin hormones, which in turn stimulate the release of insulin and reduce the production of glucagon – both of which help lower blood sugar levels.

Storage Instructions

Store Emjard l tab 5/25mg 14s at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the medication if it has expired.

Usage & Safety

Directions for Use

1. Take Emjard l tab 5/25mg 14s as directed by your healthcare provider.

2. Swallow the tablet whole with a full glass of water.

3. It is usually taken once daily, with or without food.

4. Do not crush or chew the tablet.

Precautions

Precautions

Inform your doctor about any other medications you are taking before starting Emjard l tab 5/25mg 14s.

- Monitor your blood sugar levels regularly as directed by your healthcare provider.

- Avoid consuming excessive amounts of alcohol while taking this medication.

- Seek medical attention if you experience any signs of allergic reaction or severe side effects.

Additional Information

Manufacturer Information

HOECHST PAK LTD is the manufacturer of Emjard l tab 5/25mg 14s. They are committed to providing high-quality pharmaceutical products to improve the health and well-being of individuals worldwide.